Robert Lenz

6.0k total citations · 4 hit papers
77 papers, 4.4k citations indexed

About

Robert Lenz is a scholar working on Psychiatry and Mental health, Surgery and Molecular Biology. According to data from OpenAlex, Robert Lenz has authored 77 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 21 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Robert Lenz's work include Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (15 papers) and Nicotinic Acetylcholine Receptors Study (10 papers). Robert Lenz is often cited by papers focused on Migraine and Headache Studies (25 papers), Trigeminal Neuralgia and Treatments (15 papers) and Nicotinic Acetylcholine Receptors Study (10 papers). Robert Lenz collaborates with scholars based in United States, Germany and United Kingdom. Robert Lenz's co-authors include Daniel D. Mikol, Uwe Reuter, Messoud Ashina, Jan Lewis Brandes, Hernàn Picard, Peter J. Goadsby, Stephen D. Silberstein, Stewart J. Tepper, Bradley E. Alger and Feng Zhang and has published in prestigious journals such as New England Journal of Medicine, Journal of Neuroscience and Neurology.

In The Last Decade

Robert Lenz

74 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Erenumab for Episodic Migraine

2017 631 citations Peter J. Goadsby, Uwe Reuter et al. New England Journal of Medicine profile →
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

2017 538 citations Stewart J. Tepper, Messoud Ashina et al. profile →
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

2013 487 citations Per Odin, Alberto J. Espay et al. profile →
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

2018 423 citations David W. Dodick, Messoud Ashina et al. profile →

Peers

Countries citing papers authored by Robert Lenz

Since Specialization

Citations

This map shows the geographic impact of Robert Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lenz more than expected).

Fields of papers citing papers by Robert Lenz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lenz. The network helps show where Robert Lenz may publish in the future.

Co-authorship network of co-authors of Robert Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lenz. A scholar is included among the top collaborators of Robert Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lenz. Robert Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What makes an orthopaedic paper highly citable? A bibliometric analysis of top orthopeadic journals with 10‐year follow up 2023 ·Journal of Experimental Orthopaedics ·(unknown), Henrik Rudolf, Robert Lenz, Thilo Hotfiel, Thomas Tischer	2
2	Comparison between dedicated MRI and symphyseal fluoroscopic guided contrast agent injection in the diagnosis of cleft sign in athletic groin pain and association with pelvic ring instability 2023 ·European Radiology ·(unknown), (unknown), Thomas Tischer, (unknown), (unknown), Robert Lenz, Marc‐André Weber	1
3	Predictors for an unsuccessful conservative treatment of patients with medial patellar plica syndrome 2020 ·Archives of Orthopaedic and Trauma Surgery ·Fabian Blanke, (unknown), (unknown), Thomas Tischer, Stephan Vogt, Robert Lenz	2
4	Impact of compression stockings on leg swelling after arthroscopy – a prospective randomised pilot study 2019 ·BMC Musculoskeletal Disorders ·(unknown), (unknown), Robert Lenz, Peter Kreuz, Wolfram Mittelmeier, Rainer Bader, Thomas Tischer	12
5	Was erwarten Orthopäden und Unfallchirurgen vom Radiologen bei der Beurteilung der Bildgebung des Ellenbogens? 2018 ·Der Radiologe ·Robert Lenz, (unknown), Wolfram Mittelmeier, Martin Ellenrieder, Thomas Tischer	2
6	Efficacy of erenumab in subjects with episodic migraine with prior preventive treatment failure(s) 2017 ·Ghent University Academic Bibliography (Ghent University) ·Peter J. Goadsby, Koen Paemeleire, Gregor Broessner, Jan Lewis Brandes, Jan Klatt, Feng Zhang, Hernàn Picard, Daniel D. Mikol, Robert Lenz	8
7	A Controlled Trial of Erenumab for Episodic Migraine breakdown → 2017 ·New England Journal of Medicine ·Peter J. Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo Bonner, Feng Zhang, Sandhya Sapra, Hernàn Picard, Daniel D. Mikol, Robert Lenz	631
8	Patient-Reported Outcomes in Patients with Chronic Migraine Receiving Placebo or Erenumab (AMG 334) in a Phase 2, Randomized, Double-Blind Study (P2.167) 2017 ·Neurology ·Stewart J. Tepper, Richard B. Lipton, Uwe Reuter, Stephen D. Silberstein, Walter F. Stewart, (unknown), Pooja Desai, Sunfa Cheng, (unknown), Robert Lenz	2
9	ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension 2016 ·Alzheimer s Research & Therapy ·Laura M. Gault, Robert Lenz, Craig Ritchie, Andreas Meier, Ahmed A. Othman, Qi Tang, Scott Berry, Yili Pritchett, Weining Robieson	33
10	Injektionen an Muskeln, Sehnen und Gelenken 2016 ·Der Orthopäde ·Robert Lenz, Matthias Kieb, Paula Diehl, Casper Grim, Stefan Vogt, Thomas Tischer	4
11	Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001) 2016 ·Neurology ·Robert Lenz, David W. Dodick, Peter J. Goadsby, Stephen D. Silberstein, Uwe Reuter, Messoud Ashina, Joel R. Saper, Roger Cady, Feng Zhang, Marie‐Louise Trotman, Julie Dietrich, Hong Sun	1
12	Cell viability, collagen synthesis and cytokine expression in human osteoblasts following incubation with generated wear particles using different bone cements 2013 ·International Journal of Molecular Medicine ·Christoph Schulze, (unknown), Anika Jonitz‐Heincke, Robert Lenz, (unknown), Doris Hansmann, Rainer Bader	14
13	Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results 2013 ·Parkinsonism & Related Disorders ·Hubert H. Fernandez, Arvydas Vanagunas, Per Odin, Alberto J. Espay, Robert A. Hauser, David G. Standaert, Krai Chatamra, Janet Benesh, Yili Pritchett, Steven Hass, Robert Lenz	73
14	Muskuloskelettale Modellierung des patellofemoralen Gelenks 2012 ·Der Orthopäde ·Sven Herrmann, Robert Lenz, (unknown), Sebastian Lehner, Robert Souffrant, Christoph Woernle, Thomas Tischer, Rainer Bader	3
15	The scopolamine model as a pharmacodynamic marker in early drug development 2011 ·Psychopharmacology ·Robert Lenz, Jeffrey D. Baker, Charles Locke, Lynne E. Rueter, Eric G. Mohler, Keith Wesnes, Walid Abi‐Saab, Mario Saltarelli	47
16	Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study 2009 ·Pediatric Neurology ·Robert Lenz, Roy D. Elterman, Weining Robieson, (unknown), Mario Saltarelli	2
17	Response of human osteoblasts exposed to wear particles generated at the interface of total hip stems and bone cement 2008 ·Journal of Biomedical Materials Research Part A ·Robert Lenz, Wolfram Mittelmeier, Doris Hansmann, (unknown), Peter Diehl, Andreas Fritsche, Rainer Bader	32
18	Presynaptic factors in the regulation of DSI expression in hippocampus 2002 ·Neuropharmacology ·(unknown), Darrin H. Brager, Wade Morishita, Robert Lenz, Barry London, Bradley E. Alger	32
19	N‐ and L‐type calcium channel involvement in depolarization‐induced suppression of inhibition in rat hippocampal CA1 cells 1998 ·The Journal of Physiology ·Robert Lenz, John J. Wagner, Bradley E. Alger	61
20	Central and peripheral cardio-respiratory effects of saxitoxin (STX) in urethane-anesthetized guinea-pigs 1993 ·Toxicon ·(unknown), Bernard J. Benton, Robert Lenz, Benedict R. Capacio	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact